Is a complete NSE/VIVIMEDLAB research report available?

No complete published report is available for nse/VIVIMEDLAB (NSE/VIVIMEDLAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/VIVIMEDLAB (NSE/VIVIMEDLAB)

National Stock Exchange of India: NSE/VIVIMEDLAB · INR

₹6.03

-0.12 (-1.9%)· Recorded snapshot

Market cap	500M
Revenue (ttm)	763.1M
Net income (ttm)	-1.8B
EPS (ttm)	-₹21.2
Shares out	82.9M
Volume	21,885
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 763.1M
Net income (ttm): -1.8B
EPS (ttm): -₹21.2
Market cap: 500M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All NSE/VIVIMEDLAB indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

INR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	586
Employees Change	-64%
Employees Change Percent	-9.85
Enterprise value	INR 4.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.37
Industry PE Fwd	33.73
Isin	INE526G01021
Last refreshed	2026-09-12
Market cap	INR 500M
Price	INR 6.03
Price currency	INR
Rev Per Employee	1,302,184.3x
Sector	Healthcare
Sector PE	47.89
Sector PE Fwd	38.25
Sic	2800
Symbol	nse/VIVIMEDLAB
Website	https://www.vivimedlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-352.96%
EV/FCF	66.01x
EV/Sales	5.84x
FCF yield	13.51%
P/B ratio	-0.24x
P/S ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-225.62%
EBITDA Margin	-191.48%
FCF margin	8.85%
Gross margin	3.36%
Gross Profit	INR 25.6M
Gross Profit Growth	-95.66%
Gross Profit Growth5 Y	-65.06%
Net Income	INR -1.8B
Net Income Growth Years	0%
Pretax Margin	-231.08%
Profit Margin	-231.26%
Profit Per Employee	INR -3M
ROA	-12.85
Roa5y	-6.01
ROCE	-56.38
ROIC	-56.38
Roic5y	-19.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Div CAGR3	-12.64%
Div CAGR5	-7.79%
EPS Growth Years	0
FCF Growth3 Y	-39.4%
FCF Growth5 Y	-58.77%
OCF Growth10 Y	-25.89%
OCF Growth3 Y	-39.81%
OCF Growth5 Y	-57.68%
Revenue Growth	-36.75x
Revenue Growth Q	-40.51x
Revenue Growth Qo Q	11x
Revenue Growth Years	0x
Revenue Growth3 Y	-25.97x
Revenue Growth5 Y	-38.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.09
Assets	INR 7.5B
Cash	INR 13.6M
Current Assets	INR 1.7B
Current Liabilities	INR 4.5B
Debt	INR 4B
Debt FCF	INR 58.81
Equity	INR -2.1B
Interest Coverage	-41.29
Liabilities	INR 9.6B
Long Term Assets	INR 5.9B
Long Term Liabilities	INR 5.2B
Net Cash	INR -4B
Net Cash By Market Cap	INR -792
Net Debt FCF	INR 58.61
Tangible Book Value	INR -3.6B
Tangible Book Value Per Share	INR -43.31
WACC	1.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.37
Inventory Turnover	2.06
Net Working Capital	INR 443.4M
Quick ratio	0.1
Working Capital	INR -2.8B
Working Capital Turnover	INR -0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.63%
Dividend per share	INR 0
Last Dividend	INR 0.4

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	5.66
All Time High	29.4
All Time High Change	-79.49%
All Time High Date	2025-12-18
All Time Low	4.75
All Time Low Change	26.95%
All Time Low Date	2026-08-11
ATR	0.21
Beta	0.82
Beta1y	-1.69
Beta2y	-0.96
Ch YTD	-65.87
High	6.03
High52	29.4
High52 Date	2025-12-18
High52ch	-79.49%
Low	6.03
Low52	4.75
Low52 Date	2026-08-11
Low52ch	26.95%
Ma50ch	6.61%
RSI	46.98
RSI Monthly	0
RSI Weekly	29.71
Sharpe ratio	-3.47x
Sortino ratio	-4.15
Total Return	-0.63%
Tr YTD	-65.87
Tr1m	23.57%
Tr1w	-7.8%
Tr3m	-3.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,665,300%
Net Borrowing	-19,360,000
Shares Insiders	11.57%
Shares Institutions	6.94%
Shares Out	82,913,915
Shares Qo Q	0.2%
Shares Yo Y	0.63%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	96,250.75x
Bv Per Share	-25.39
CAPEX	INR -9.5M
Ch1m	23.57
Ch1w	-7.8
Ch3m	-3.05
Ch6m	-11.71
Change	-1.95%
Change From Open	0
Close	6.15
Days Gap	-1.95
Depreciation Amortization	260,520,000
Dollar Volume	131,966.6
Earnings Date	2026-08-28
EBIT	INR -1.7B
EBITDA	INR -1.5B
EPS	INR -21.15
F Score	2
FCF	INR 67.6M
FCF EV Yield	1.51x
FCF Per Share	INR 0.81
Financing CF	-61,070,000
Fiscal Year End	March
Founded	1,988
Income Tax	INR 1.4M
Investing CF	-9,470,000
Is Primary Listing	1
Last Earnings Date	2026-07-17
Last Report Date	2026-03-31
Last Split Date	2016-04-06
Last Split Type	Forward
Ma150	6.34
Ma150ch	-4.86%
Ma20	6.36
Ma20ch	-5.2%
Net CF	6,480,000
Open	6.03
P FCF Ratio	7.4
P OCF Ratio	6.49
Ppne	2,548,010,000
Price Date	2026-09-11
Relative Volume	0.23x
Revenue	763,080,000x
Tax By Revenue	0.18x
Tr6m	-11.71%
Volume	21,885

NSE/VIVIMEDLAB (NSE/VIVIMEDLAB)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/VIVIMEDLAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/VIVIMEDLAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/VIVIMEDLAB

Frequently asked questions